Latest Breaking News On - Scandinavian chemotech - Page 1 : comparemela.com

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Scandinavian ChemoTech AB (535/23)

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Scandinavian ChemoTech AB (535/23)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Ihre chancenIndiens wirtschaftScandinavian chemotechFirst north growthEuroclear swedenFirst northIssuer surveillanceNasdaq stockholmDer indienDie highlights

Scandinavian ChemoTech publishes an interview with newly appointed chairman of the board Robin Sukhia

On May 16, 2023, Robin Sukhia was elected as the new chairman of the board for Scandinavian ChemoTech. In an interview with ChemoTech s head of investor relations, Jonathan Furelid, he gives his view. | June 14, 2023

United statesScandinavian chemotechRobin sukhiaJonathan furelidMohan frickSweden india business councilUniversity hospitalIndia business councilRoyal veterinary collageFlorida wildTumour specific electroporationNasdaq first north growth market

Scandinavian ChemoTech provides update on pancreas patients in Ukraine - aims for multinational TSE-studies in cooperation with partners as the next step

/PRNewswire/ In September 2022, two locally advanced pancreatic cancer patients received TSE treatment at Ulis Hospital in Ukraine by open surgery. The.

United statesMohan frickScandinavian chemotechSulis hospitalProfessor alexei kovalevMedtech summitPancreatic cancerTumour specific electroporationNasdaq first north growth marketPress releaseStatus update

Redeye Initiates Coverage of Scandinavian ChemoTech

Redeye initiates coverage of Scandinavian ChemoTech, a Swedish medtech company in early-stage commercialisation with its tumour-specific electroporation treatment method for both humans and animal. | March 15, 2023

Scandinavian chemotechResearch powered investment bankingLife sciencePowered investmentScandinavian chemotech ab publ stock exchangePress releaseNd cmotecb se0009242654

TSE treatments at the Royal Veterinary College shows very promising results

/PRNewswire/ Scandinavian ChemoTech s fully owned subsidiary Vetiqure receives very promising updates from the veterinarians at the Royal Veterinary College.

United statesScandinavian chemotechMohan frickPrnewswire scandinavian chemotechRoyal veterinary collegeAbuse regulationTumour specific electroporationNasdaq first north growth marketHealth care amp hospitalsMedical pharmaceuticalsMedical equipmentAnimal welfareClinical trials amp medical discoveries